Amgen Inc. raises 2025 revenue guidance on strong Repatha and Imdelltra sales and dividend hike. Click for this AMGN update.
MedPage Today on MSN
Once-Weekly Oral Combo for HIV Maintains High Rates of Virologic Suppression
A once-weekly oral combination of islatravir plus lenacapavir (Sunlenca) for HIV maintained similarly high rates of virologic ...
ZME Science on MSN
Our Favorite Science Stories That Stuck With Us From 2025
Thirty years ago, astronomers weren’t sure planets beyond our solar system even existed. This year, NASA has confirmed its ...
Zacks.com on MSN
GILD Exercises Option to License Assembly Bio's Herpes Programs
Gilead exercises its option to license ASMB's HSV programs for developing long-acting candidates, ABI-1179 & ABI-5366, for recurrent genital herpes.
The Manila Times on MSN
HPV vaccine developers, hybrid rice innovators top 2025 VinFuture Prize
DECADES of virology research that yielded the human papillomavirus (HPV) vaccine and identified the virus as a primary cause ...
Modern Engineering Marvels on MSN
Newly found microbe redefines the edge of life
Can life exist without the very metabolic machinery that defines it? The discovery of Candidatus Sukunaarchaeum mirabile ...
This article explores limitations of chemical synthesis in high-throughput settings and the technical advantages enzymatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results